IAG Wins in the 2024 Pharmaceutical Technology Excellence Awards
Image Analysis Group (IAG) has won an award in the Innovation Category in the 2024 Pharmaceutical Technology Excellence Awards for its platform DYNAMIKA.
The Pharmaceutical Technology Excellence Awards celebrate the greatest achievements and innovations in the pharmaceuticals industry.
Powered by GlobalData’s business intelligence, the Awards recognize the people and companies that are driving change in the industry.
Read more about the award in this article from Pharmaceutical Technology.
About DYNAMIKA:
DYNAMIKA is an industry-leading platform for central image review and analysis in clinical trials. It is a cloud-native intelligent enterprise workflow solution brought by IAG team to simplify and modernize central data collection, quality control and central review in global clinical trials. IAG’s platform integrates automated workflow and artificial intelligence (AI) to enhance trial efficiency, streamline global data management, and ensure robust security measures. DYNAMIKA reduces burden on the clinical sites, takes away manual tasks of image anonymization and quality control. It powers radiology workflows and reads, reduces readers’ time and increases reproducibility. It brings best-in-class library of AI tools to enable multiple radiology use cases. DYNAMIKA serves as a central trusted hub for image collection, secure management, and instant access. It is recently re-accredited with ISO13485 by the British Standards Institute and developed in compliance with 21 CFR part 11 standard for clinical trials.
About Image Analysis Group (IAG):
Leading imaging Clinical Research Organization (iCRO) that combines medical and operational expertise with cutting-edge proprietary A.I. capabilities to power drug development, and to deliver the potential for companion diagnostic tool. IAG has been serving biotech and pharma clients globally since 2007, reliably supporting all aspects of phase I to III imaging trials across multiple indications. With a pioneering proven innovation strategy, we enhance the value and market potential of novel therapeutic assets, as demonstrated through successful pharmaceutical partnerships.
Learn more: ia-grp.com
Follow the Company: Linkedin